Matt Dellatorre

Stock Analyst at Goldman Sachs

(0.31)
# 4,218
Out of 4,906 analysts
2
Total ratings
n/a
Success rate
-8.49%
Average return

Stocks Rated by Matt Dellatorre

Viatris
Jun 6, 2025
Initiates: Neutral
Price Target: $10
Current: $8.90
Upside: +12.36%
Teva Pharmaceutical Industries
Jun 6, 2025
Initiates: Buy
Price Target: $24
Current: $16.31
Upside: +47.15%